Ali Riza Nazari, MD
Family Medicine Physician in Bellingham, Washington.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 147,760 in Family Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Ali Riza Nazari, MD reported a CMS MIPS final score of 90.8/100 - above the 83.5 national average - and filed 2,620 Medicare Part D claims in 2023.
- 90.8/100
- MIPS score · +7 vs avg
- 3K
- Part D claims, 2023
- 81%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1104278829 · Family Medicine Physician
NPI-10 · ENUM-MID · TAX-MEGA · MIPS-ABOVE · RX-MID · BOOK-MID · PHOTO-FINISH
- NPI-10 1104278829
- ENUM-MID 2016
- TAX-MEGA 148K Family Medicine
- MIPS-ABOVE 90.8/100
- RX-MID 2,620
- BOOK-MID 5,197 in Washington
- PHOTO-FINISH Brittany Barnes · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Nazari · this pr…
Nazari · this provider
90.8 MIPS pts
- Jeffrey Brinker …
Jeffrey Brinker
90.8 MIPS pts
- Brittany Barnes …
Brittany Barnes
90.8 MIPS pts
- Rachel Bixler · …
Rachel Bixler
90.8 MIPS pts
- Michelle Brandho…
Michelle Brandhorst
90.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Ali Riza Nazari, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
91 ≥ 58th percentile 58% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Ali Riza Nazari, MD sits
This provider among family medicine physician peers
Across the 21,266 family medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Ali Riza Nazari, MD writes more Part D claims than 50% of them and scores higher on MIPS quality than 60% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one family medicine physician peer from a representative sample of 60; the gold marker is Ali Riza Nazari, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Ali Riza Nazari, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ali Riza Nazari, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Washington
How Family Medicine Physician compares to other specialties among Washington providers
Family Medicine Physician ranks #10 among Washington's specialties (2.6% of in-state providers)
Each bar is a specialty's share of the Washington provider total, by primary NUCC taxonomy. The highlighted bar is Family Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Ali Riza Nazari, MD's 2023 MIPS final score plotted against the Family Medicine Physician national average
- MIPS Final Score
- 90.8/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Family Medicine Physician US NPIs
90.8/100 MIPS final score - 7.3 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Family Medicine Physician. Quality dim: 81.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1104278829 |
|---|---|
| Specialty | Family Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/06/2016 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Ali Riza Nazari, MD's current license status, disciplinary history, and board certifications with the Washington State Department of Health, Medical Quality Assurance Commission in Washington before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1104278829 is the unique 10-digit identifier CMS uses to link Nazari across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Ali Riza Nazari, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ali Riza Nazari, MD. Source: openpaymentsdata.cms.gov.
Total received
$341
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Washington WMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 - they are NOT specific to Ali Riza Nazari, MD. To verify Ali Riza Nazari, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
17% brand-name claims vs 81% generic, on 2,620 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 5,853
- Total Day Supply
- 169,426
- Brand vs Generic
- 17% brand / 81% generic
- Brand Drug Cost
- $370K
- Generic Drug Cost
- $42K
- Opioid Claims
- 30 (1.1% rate)
- Antibiotic Claims
- 63
Patient Demographics
- Average Patient Age
- 68.4 years
- Avg HCC Risk Score
- 1.48
- Gender Split
- 53% female / 47% male
- Age Distribution
- <65: 67, 65-74: 123, 75-84: 63, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ali Riza Nazari, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Amlodipine Besylate
Amlodipine Besylate
143 claims
- Atorvastatin Calcium
Atorvastatin Calcium
140 claims
- Losartan Potassium
Losartan Potassium
83 claims
- Pantoprazole Sodium
Pantoprazole Sodium
75 claims
- Trazodone Hcl
Trazodone Hcl
73 claims
- Metformin Hcl Er
Metformin Hcl Er
67 claims
- Trulicity
Trulicity
66 claims
- Gabapentin
Gabapentin
64 claims
| Drug | Claims |
|---|---|
| Amlodipine Besylate | 143 |
| Atorvastatin Calcium | 140 |
| Losartan Potassium | 83 |
| Pantoprazole Sodium | 75 |
| Trazodone Hcl | 73 |
| Metformin Hcl Er Metformin Hcl | 67 |
| Trulicity Dulaglutide | 66 |
| Gabapentin | 64 |
| Hydrochlorothiazide | 64 |
| Mounjaro Tirzepatide | 63 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Medicine Physician Overview
How Ali Riza Nazari, MD fits within the Family Medicine Physician landscape nationally.
Ali Riza Nazari, MD's 2,620 claims are below the specialty average of 3,418.
Nationwide Family Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Nazari, both outside Washington so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (90.8 here).
Same NPPES enumeration year (2016)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Family Medicine Physician Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as Nazari.
One of 5,197 Family Medicine Physician providers enrolled in Washington, 5 are shown here.
Compare Family Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Ali Riza Nazari, MD's specialty? ▼
How much does Ali Riza Nazari, MD prescribe under Medicare Part D? ▼
What is Ali Riza Nazari, MD's Medicare quality score? ▼
Where is Ali Riza Nazari, MD located? ▼
What is Ali Riza Nazari, MD's NPI number? ▼
Does Ali Riza Nazari, MD prescribe more brand-name or generic drugs? ▼
Does Ali Riza Nazari, MD prescribe opioids? ▼
How many Family Medicine Physician providers are there in the US? ▼
What drugs does Ali Riza Nazari, MD prescribe most often? ▼
Does Ali Riza Nazari, MD accept Medicare? ▼
How can I verify Ali Riza Nazari, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.